Nov 06, 2024 / 02:00PM GMT
Operator
Welcome to Carnegie and this Q3 report presentation with Senzime.
My name is Klas Palin and I'm an equity analyst and have coverage of Senzime and I will be responsible for the Q&A session. But before that, we will listen to a company presentation and a presentation of the development in Q3, which will be held by CEO Philip Siberg.
Philip, very welcome. And please you may start your presentation.
Philip Siberg - Senzime AB(publ)-Chief Executive Officer
Okay. And thank you for listening to this quarterly Q3 report 2024. Okay. So Senzime, quick recap, I mean, we're a medical device company. We develop solutions to radically change and improve anaesthesia practice. So it's about helping patients throughout their journey from preoperative care and making sure they get the right dose of anaesthetic drugs and are excavated so they can wake up at the right time.
Our business is in around the Tegra system which is our predominant focus area. The Tegra system is used in thousands of operating rooms around
Q3 2024 Senzime AB (publ) Earnings Call Transcript
Nov 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers